-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32

Benzinga·08/11/2026 17:41:29
Listen to the news
Stifel analyst Daniel Arias maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $28 to $32.